Tapewire

NYSE · USD

MET

METLIFE INC

Export transactions ↓
Tapewire entity
488
SEC CIK
0001099219
Parsed reports
1,091

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 03, 2023 Filed Jan 5, 2023 21:30 UTC GrantCommon Stock 520 $0.00 $0.00
Disclosure

SEC source: 0001099219-23-000032 · wf-form4_167295418787528.xml · nonDerivative · entry 1

Kinney Catherine R · CIK 0001205054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,514

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:29 UTC GrantCommon Stock 953 $72.15 $68,758.95
Disclosure

SEC source: 0001099219-23-000031 · wf-form4_167295416137518.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,124

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:29 UTC GrantCommon Stock 520 $72.15 $37,518.00
Disclosure

SEC source: 0001099219-23-000030 · wf-form4_167295413463105.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,808

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:28 UTC GrantCommon Stock 520 $72.15 $37,518.00
Disclosure

SEC source: 0001099219-23-000029 · wf-form4_167295410318710.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,303

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:27 UTC GrantCommon Stock 520 $0.00 $0.00
Disclosure

SEC source: 0001099219-23-000026 · wf-form4_167295403363378.xml · nonDerivative · entry 1

MORRISON DENISE M · CIK 0001230166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,475

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:28 UTC GrantCommon Stock 520 $72.15 $37,518.00
Disclosure

SEC source: 0001099219-23-000028 · wf-form4_167295407591539.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,019

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:27 UTC GrantCommon Stock 520 $72.15 $37,518.00
Disclosure

SEC source: 0001099219-23-000025 · wf-form4_167295400366113.xml · nonDerivative · entry 1

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,966

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
December 23, 2022 Filed Apr 19, 2023 21:04 UTC SaleCommon Stock 6 $72.24 $433.44
Disclosure

SEC source: 0001099219-23-000143 · wf-form4_168193828509148.xml · nonDerivative · entry 2

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,213

F1 · kind: These transactions were executed by an unaffiliated broker for an account of the reporting person managed by such broker, despite a trading restriction in the account prohibiting transactions in securities of the issuer. The broker did not discuss these transactions with the reporting person at the time the trades were made and the reporting person only recently became aware that such unauthorized transactions had occurred.

Read SEC document
December 20, 2022 Filed Dec 22, 2022 21:15 UTC
PODLOGAR SUSAN MEVP & Chief HR Officer
SaleCommon Stock 3,000 $71.91 $215,730.00
Disclosure

SEC source: 0001099219-22-000205 · wf-form4_167174371072649.xml · nonDerivative · entry 1

PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,193

Read SEC document
December 14, 2022 Filed Dec 16, 2022 21:25 UTC GrantCommon Stock 94 $72.84 $6,846.96
Disclosure

SEC source: 0001099219-22-000203 · wf-form4_167122589949781.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,830

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 14, 2022 Filed Dec 16, 2022 21:25 UTC GrantCommon Stock 230 $72.84 $16,753.20
Disclosure

SEC source: 0001099219-22-000202 · wf-form4_167122587686728.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,783

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 14, 2022 Filed Dec 16, 2022 21:24 UTC GrantCommon Stock 193 $72.84 $14,058.12
Disclosure

SEC source: 0001099219-22-000201 · wf-form4_167122585590317.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,288

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 14, 2022 Filed Dec 16, 2022 21:24 UTC GrantCommon Stock 489 $72.84 $35,618.76
Disclosure

SEC source: 0001099219-22-000200 · wf-form4_167122583498926.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,499

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 14, 2022 Filed Dec 16, 2022 21:23 UTC GrantCommon Stock 240 $72.84 $17,481.60
Disclosure

SEC source: 0001099219-22-000199 · wf-form4_167122581568996.xml · nonDerivative · entry 1

Kinney Catherine R · CIK 0001205054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,994

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 14, 2022 Filed Dec 16, 2022 21:23 UTC GrantCommon Stock 507 $72.84 $36,929.88
Disclosure

SEC source: 0001099219-22-000198 · wf-form4_167122579857795.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,171

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 14, 2022 Filed Dec 16, 2022 21:23 UTC GrantCommon Stock 39 $72.84 $2,840.76
Disclosure

SEC source: 0001099219-22-000197 · wf-form4_167122577852510.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,749

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 14, 2022 Filed Dec 16, 2022 21:22 UTC GrantCommon Stock 112 $72.84 $8,158.08
Disclosure

SEC source: 0001099219-22-000196 · wf-form4_167122575457392.xml · nonDerivative · entry 1

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,446

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 21:20 UTC
Goulart Steven JEVP & Chief Investment Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 40,704 $0.00 Strike: $31.15 $0.00
Disclosure

SEC source: 0001099219-22-000187 · wf-form4_167105282073539.xml · derivative · entry 3

Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,704 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Includes 4,340 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options.

F4 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 26, 2014, 2015 and 2016.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 21:20 UTC
Goulart Steven JEVP & Chief Investment Officer
SaleCommon Stock 29,401 $71.88 $2,113,235.10
Disclosure

SEC source: 0001099219-22-000187 · wf-form4_167105282073539.xml · nonDerivative · entry 2

Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,310

F1 · shares: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on December 12, 2022 and related tax obligations and fees.

F2 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $71.59 and $72.27, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 21:20 UTC
Goulart Steven JEVP & Chief Investment Officer
Exercise / conversionCommon Stock 40,704 $31.15 $1,267,929.60
Disclosure

SEC source: 0001099219-22-000187 · wf-form4_167105282073539.xml · nonDerivative · entry 1

Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 302,711

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 21:16 UTC
Khalaf MichelDirector · President & CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 39,322 $0.00 Strike: $34.33 $0.00
Disclosure

SEC source: 0001099219-22-000186 · wf-form4_167105257565012.xml · derivative · entry 5

Khalaf Michel · CIK 0001535491 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 39,322 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Includes 4,193 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options.

F6 · derivative.exercise_date: The options become exercisable in three substantially equal installments on February 23, 2016, 2017 and 2018.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 21:16 UTC
Khalaf MichelDirector · President & CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 35,616 $0.00 Strike: $31.15 $0.00
Disclosure

SEC source: 0001099219-22-000186 · wf-form4_167105257565012.xml · derivative · entry 4

Khalaf Michel · CIK 0001535491 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,616 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Includes 3,798 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options.

F4 · derivative.exercise_date: The options become exercisable in three substantially equal installments on February 26, 2014, 2015 and 2016.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 21:16 UTC
Khalaf MichelDirector · President & CEO
SaleCommon Stock 57,201 $72.49 $4,146,637.77
Disclosure

SEC source: 0001099219-22-000186 · wf-form4_167105257565012.xml · nonDerivative · entry 3

Khalaf Michel · CIK 0001535491 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,618

F1 · shares: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on December 12, 2022 and related tax obligations and fees.

F2 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $72.38 to $72.865, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 21:16 UTC
Khalaf MichelDirector · President & CEO
Exercise / conversionCommon Stock 39,322 $34.33 $1,349,924.26
Disclosure

SEC source: 0001099219-22-000186 · wf-form4_167105257565012.xml · nonDerivative · entry 2

Khalaf Michel · CIK 0001535491 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 321,819

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 21:16 UTC
Khalaf MichelDirector · President & CEO
Exercise / conversionCommon Stock 35,616 $31.15 $1,109,438.40
Disclosure

SEC source: 0001099219-22-000186 · wf-form4_167105257565012.xml · nonDerivative · entry 1

Khalaf Michel · CIK 0001535491 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 282,497

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 07, 2022 Filed Dec 9, 2022 21:19 UTC
PAPPAS BILLEVP, Global Tech. & Ops.
SaleCommon Stock 5,000 $75.55 $377,725.00
Disclosure

SEC source: 0001099219-22-000181 · wf-form4_167062077671937.xml · nonDerivative · entry 1

PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,147

Read SEC document
November 18, 2022 Filed Nov 22, 2022 21:17 UTC
PAPPAS BILLEVP, Global Tech. & Ops.
Tax withholdingCommon Stock 9,349 $75.50 $705,849.50
Disclosure

SEC source: 0001099219-22-000179 · wf-form4_166915185805954.xml · nonDerivative · entry 1

PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,147

F1 · kind: Withheld for taxes on shares issued for restricted stock units.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 20:30 UTC GrantCommon Stock 599 $62.62 $37,509.38
Disclosure

SEC source: 0001099219-22-000170 · wf-form4_166500181271382.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,096

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 20:30 UTC GrantCommon Stock 599 $62.62 $37,509.38
Disclosure

SEC source: 0001099219-22-000169 · wf-form4_166500178969194.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,710

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 20:29 UTC GrantCommon Stock 599 $62.62 $37,509.38
Disclosure

SEC source: 0001099219-22-000168 · wf-form4_166500176724775.xml · nonDerivative · entry 1

GUTIERREZ CARLOS M · CIK 0001185943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,989

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 20:29 UTC GrantCommon Stock 599 $62.62 $37,509.38
Disclosure

SEC source: 0001099219-22-000167 · wf-form4_166500174312445.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,010

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 20:28 UTC GrantCommon Stock 599 $62.62 $37,509.38
Disclosure

SEC source: 0001099219-22-000166 · wf-form4_166500172332928.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,735

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 20:28 UTC GrantCommon Stock 1,098 $62.62 $68,756.76
Disclosure

SEC source: 0001099219-22-000165 · wf-form4_166500169576590.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,664

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees and 50% of Board Chair retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 20:28 UTC GrantCommon Stock 599 $62.62 $37,509.38
Disclosure

SEC source: 0001099219-22-000164 · wf-form4_166500167314788.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,552

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 20:27 UTC GrantCommon Stock 599 $62.62 $37,509.38
Disclosure

SEC source: 0001099219-22-000163 · wf-form4_166500165064586.xml · nonDerivative · entry 1

Kinney Catherine R · CIK 0001205054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,754

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 20:27 UTC GrantCommon Stock 599 $62.62 $37,509.38
Disclosure

SEC source: 0001099219-22-000162 · wf-form4_166500163202516.xml · nonDerivative · entry 1

Harris Carla A · CIK 0001707351 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,532

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 20:27 UTC GrantCommon Stock 599 $62.62 $37,509.38
Disclosure

SEC source: 0001099219-22-000161 · wf-form4_166500161366378.xml · nonDerivative · entry 1

WEINBERGER MARK A · CIK 0001785997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,045

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 20:26 UTC GrantCommon Stock 599 $62.62 $37,509.38
Disclosure

SEC source: 0001099219-22-000160 · wf-form4_166500158718445.xml · nonDerivative · entry 1

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,334

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 20:26 UTC GrantCommon Stock 599 $62.62 $37,509.38
Disclosure

SEC source: 0001099219-22-000159 · wf-form4_166500157025181.xml · nonDerivative · entry 1

MORRISON DENISE M · CIK 0001230166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,955

F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.

Read SEC document
September 14, 2022 Filed Sep 16, 2022 20:26 UTC GrantCommon Stock 544 $66.41 $36,127.04
Disclosure

SEC source: 0001099219-22-000146 · wf-form4_166335999038060.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,566

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 14, 2022 Filed Sep 16, 2022 20:26 UTC GrantCommon Stock 528 $66.41 $35,064.48
Disclosure

SEC source: 0001099219-22-000145 · wf-form4_166335997355229.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,411

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 14, 2022 Filed Sep 16, 2022 20:25 UTC GrantCommon Stock 261 $66.41 $17,333.01
Disclosure

SEC source: 0001099219-22-000143 · wf-form4_166335993789703.xml · nonDerivative · entry 1

Kinney Catherine R · CIK 0001205054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,155

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 14, 2022 Filed Sep 16, 2022 20:26 UTC GrantCommon Stock 98 $66.41 $6,508.18
Disclosure

SEC source: 0001099219-22-000144 · wf-form4_166335995531873.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,136

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 14, 2022 Filed Sep 16, 2022 20:25 UTC GrantCommon Stock 246 $66.41 $16,336.86
Disclosure

SEC source: 0001099219-22-000141 · wf-form4_166335990027128.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,953

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 14, 2022 Filed Sep 16, 2022 20:25 UTC GrantCommon Stock 117 $66.41 $7,769.97
Disclosure

SEC source: 0001099219-22-000142 · wf-form4_166335991773146.xml · nonDerivative · entry 1

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,735

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 14, 2022 Filed Sep 16, 2022 20:24 UTC GrantCommon Stock 42 $66.41 $2,789.22
Disclosure

SEC source: 0001099219-22-000139 · wf-form4_166335985245241.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,111

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
September 14, 2022 Filed Sep 16, 2022 20:24 UTC GrantCommon Stock 205 $66.41 $13,614.05
Disclosure

SEC source: 0001099219-22-000140 · wf-form4_166335987075723.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,497

F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Read SEC document
August 19, 2022 Filed Aug 23, 2022 21:20 UTC
DEBEL MARLENEEVP & Chief Risk Officer
Exercise / conversionEmployee Stock Options (right to buy) · Derivative 5,513 $0.00 Strike: $31.15 $0.00
Disclosure

SEC source: 0001770295-22-000002 · wf-form4_166128964225351.xml · derivative · entry 3

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,513 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 26, 2014, 2015 and 2016.

Read SEC document
August 19, 2022 Filed Aug 23, 2022 21:20 UTC
DEBEL MARLENEEVP & Chief Risk Officer
SaleCommon Stock 4,060 $67.60 $274,456.00
Disclosure

SEC source: 0001770295-22-000002 · wf-form4_166128964225351.xml · nonDerivative · entry 2

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,299

F1 · shares: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on August 19, 2022 and related tax obligations and fees.

Read SEC document
August 19, 2022 Filed Aug 23, 2022 21:20 UTC
DEBEL MARLENEEVP & Chief Risk Officer
Exercise / conversionCommon Stock 5,513 $31.15 $171,729.95
Disclosure

SEC source: 0001770295-22-000002 · wf-form4_166128964225351.xml · nonDerivative · entry 1

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,359

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.